Zobrazeno 1 - 9
of 9
pro vyhledávání: '"S. M. Edgerton"'
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 7(8)
erbB-2 and epidermal growth factor receptor (EGFR) may mediate motility via signaling that enables changes in the actin cytoskeleton. A physical basis for this motility may depend on the coexpression of gelsolin, a M(r) 80,000 actin-binding protein.T
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 7(6)
Our objective was to investigate the prognostic significance of cell turnover (apoptosis and proliferation) in breast cancer patients. Apoptosis was microscopically quantitated on histological sections from 791 breast cancer patients with long-term f
Publikováno v:
Human pathology. 30(12)
Invasive micropapillary carcinoma (IMC) of the breast is a rare variant of infiltrating ductal carcinoma that has been associated with an extremely high incidence of lymph node metastases. Follow-up studies on patients with pure IMC breast cancer his
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 3(2)
Bax and Bcl-2 are proteins that regulate programmed cell death and apoptosis. The expression of these proteins can be regulated, at least in part, by the tumor suppressor p53, but the effects of p53 are highly tissue specific. In an effort to better
Autor:
K. Axelsson, B.-M. E. Ljung, D. H. Moore, A. D. Thor, K. L. Chew, S. M. Edgerton, H. S. Smith, B. H. Mayall
Publikováno v:
Journal of the National Cancer Institute. 87(13)
Background : Tumor angiogenesis, as assayed by microvessel density, has been proposed as an independent prognostic marker for clinical outcome in breast cancer patients. Purpose: The present study evaluated the microvessel density assay and assessed
Autor:
L H, Schwartz, F C, Koerner, S M, Edgerton, J M, Sawicka, M C, Rio, J P, Bellocq, P, Chambon, A D, Thor
Publikováno v:
Cancer research. 51(2)
Seventy-two patients with advanced breast carcinoma (42% bone, 25% visceral, 5.5% soft tissue, and 27.5% multiple site metastases) were evaluated to determine the relationship between tumor expression of the estrogen-regulated protein pS2, estrogen r
Autor:
K. AXELSSON, B.-M. E. LJUNG, K. L. CHEW, B. H. MAYALL, D. H. MOORE, H. S. SMITH, A. D. THOR, S. M EDGERTON
Publikováno v:
JNCI Journal of the National Cancer Institute. 87:1801-1802
Autor:
S. M. Edgerton
Publikováno v:
Applied Immunohistochemistry & Molecular Morphology; Sep2003, Vol. 11 Issue 3, p214, 8p
Autor:
A D, Thor, L H, Schwartz, F C, Koerner, S M, Edgerton, S J, Skates, S, Yin, S J, McKenzie, D L, Panicali, P J, Marks, H J, Fingert
Publikováno v:
Cancer research. 49(24 Pt 1)
Various monoclonal antibodies reactive with protooncogene products or tumor-associated antigens have been utilized to investigate breast carcinoma biology or antigen expression with potential prognostic relevance. Murine monoclonal antibody TA1, gene